Novartis
NVS
#53
Rank
ยฃ223.14 B
Marketcap
ยฃ118.15
Share price
1.98%
Change (1 day)
22.06%
Change (1 year)

Novartis AG is a biotechnology and pharmaceutical company based in Basel, Switzerland. Novartis was formed in 1996 from a merger of the two Basel pharmaceutical and chemical companies Ciba-Geigy AG and Sandoz AG. Novartis is one of the largest pharmaceutical companies in the world with sales of USD 47.4 billion in 2019.

Market capitalization of Novartis (NVS)

Market cap: ยฃ223.14 Billion

As of October 2026 Novartis has a market cap of ยฃ223.14 Billion. This makes Novartis the world's 53th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Novartis from 1998 to 2026

End of year Market Cap

Year Marketcap Change
2026ยฃ223.14 B12.53%
2025ยฃ198.30 B26.51%
2024ยฃ156.75 B-3.78%
2023ยฃ162.90 B1%
2022ยฃ161.29 B10.82%
2021ยฃ145.55 B-8.9%
2020ยฃ159.76 B-2.48%
2019ยฃ163.82 B5.41%
2018ยฃ155.41 B6.52%
2017ยฃ145.90 B4.07%
2016ยฃ140.19 B-0.34%
2015ยฃ140.67 B-2.23%
2014ยฃ143.88 B21.94%
2013ยฃ117.99 B25.2%
2012ยฃ94.24 B6.08%
2011ยฃ88.84 B1.91%
2010ยฃ87.18 B12.83%
2009ยฃ77.26 B0.49%
2008ยฃ76.89 B24.21%
2007ยฃ61.90 B-10.1%
2006ยฃ68.86 B-3.13%
2005ยฃ71.08 B11.27%
2004ยฃ63.88 B0.92%
2003ยฃ63.30 B11.66%
2002ยฃ56.69 B-11.62%
2001ยฃ64.14 B-17.92%
2000ยฃ78.15 B31.37%
1999ยฃ59.49 B-26.3%
1998ยฃ80.72 B

End of Day market cap according to different sources

On Oct 27th, 2026 the market cap of Novartis was reported to be:

ยฃ225.37 Billion
by Nasdaq info icon info icon
ยฃ224.57 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
ยฃ487.28 B 118.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ127.93 B-42.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
ยฃ135.26 B-39.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ75.60 B-66.12%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
ยฃ263.55 B 18.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ94.70 B-57.56%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ198.68 B-10.96%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
ยฃ76.87 B-65.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
ยฃ35.48 B-84.10%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel